ArticleJournal of medicinal chemistry2025

NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders.

Zonghui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.